Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Change in Acquisitions & Divestments (2016 - 2024)

Historic Change in Acquisitions & Divestments for Sangamo Therapeutics (SGMO) over the last 16 years, with Q1 2024 value amounting to $34.7 million.

  • Sangamo Therapeutics' Change in Acquisitions & Divestments fell 5772.52% to $34.7 million in Q1 2024 from the same period last year, while for Dec 2024 it was $34.7 million, marking a year-over-year decrease of 8380.89%. This contributed to the annual value of $34.7 million for FY2024, which is 8380.89% down from last year.
  • Per Sangamo Therapeutics' latest filing, its Change in Acquisitions & Divestments stood at $34.7 million for Q1 2024, which was down 5772.52% from $20.6 million recorded in Q4 2023.
  • In the past 5 years, Sangamo Therapeutics' Change in Acquisitions & Divestments registered a high of $186.5 million during Q3 2021, and its lowest value of $20.6 million during Q4 2023.
  • Over the past 5 years, Sangamo Therapeutics' median Change in Acquisitions & Divestments value was $82.2 million (recorded in 2023), while the average stood at $89.5 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first skyrocketed by 25060.34% in 2021, then tumbled by 7927.45% in 2023.
  • Quarter analysis of 5 years shows Sangamo Therapeutics' Change in Acquisitions & Divestments stood at $109.5 million in 2020, then fell by 14.85% to $93.3 million in 2021, then grew by 6.79% to $99.6 million in 2022, then crashed by 79.27% to $20.6 million in 2023, then surged by 68.25% to $34.7 million in 2024.
  • Its Change in Acquisitions & Divestments was $34.7 million in Q1 2024, compared to $20.6 million in Q4 2023 and $47.8 million in Q3 2023.